v3.25.4
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2025
Sep. 30, 2025
Sep. 30, 2024
Current assets:      
Cash and cash equivalents $ 37,437 $ 32,298  
Short-term marketable securities 148,412 156,566  
Accounts receivable 8,493 6,882  
Prepaid expenses and other current assets 4,342 8,590  
Total current assets 198,684 204,336  
Long-term marketable securities 56,055 0  
Property and equipment, net 34,308 35,395  
Operating lease, right-of-use assets 37,003 37,549  
Long-term restricted cash 3,360 3,360  
Other long-term assets 93 92  
Total assets 329,503 280,732  
Current liabilities:      
Accounts payable 1,885 1,948  
Accrued expenses and other current liabilities 7,575 12,751  
Liability related to the sale of future royalties 31,981 30,710  
Operating lease liabilities 3,287 3,146  
Total current liabilities 44,728 48,555  
Liability related to the sale of future royalties, net of current portion 102,822 111,132  
Operating lease liabilities, net of current portion 53,782 54,757  
Series 1 nonconvertible preferred stock 1,311 1,311  
Other long-term liabilities 269 260  
Total liabilities 202,912 216,015  
Commitments and contingencies (Note 10)  
Stockholders' equity:      
Common stock; $0.01 par value per share, 100,000 shares authorized; 29,019 and 21,387 shares issued and outstanding at December 31, 2025 and September 30, 2025, respectively 290 214  
Additional paid-in capital 543,497 469,771  
Accumulated other comprehensive loss (329) (339)  
Accumulated deficit (416,867) (404,929)  
Total stockholders' equity 126,591 64,717 $ 128,814
Total liabilities and stockholders' equity $ 329,503 $ 280,732